Rate My Professor Paul Matthews

Matthews' distinguished career encompasses clinical training, academic leadership, and industry experience. Following a neurology residency at the Montreal Neurological Institute and post-doctoral research in the Genetics Laboratory at Oxford and the Department of Pharmacology at Stanford University, he served as Assistant Professor of Neurology and Genetics at McGill University from 1994 to 1995. At the University of Oxford from 1995 to 2005, he was an MRC Clinical Research Reader and later Professor, where he founded and directed the FMRIB Centre. Between 2005 and 2014, he was Vice President at GlaxoSmithKline, overseeing the GSK Clinical Imaging Centre and Global Imaging Group. His research specializes in neuroinflammatory mechanisms of neurodegeneration, particularly in Alzheimer’s disease and multiple sclerosis, utilizing epidemiological approaches, MRI and PET imaging, and molecular omics tools to explore mitochondrial and vascular dysfunction and novel immunomodulatory targets. Recognized with the Officer of the Most Excellent Order of the British Empire (OBE) in 2008 for services to neuroscience, Fellow of the Academy of Medical Sciences, Fellow of Academia Europaea, NIHR Senior Investigator, and Fellow by Special Election of St Edmund Hall, Oxford, Matthews has chaired the UKRI MRC Neuroscience and Mental Health Board (2020–2024) and the UK Biobank Imaging Enhancement Working Group, contributing to the world’s largest population neuroimaging resource.